文献速递神经外周血管MR

药物治疗与球囊血管成形术对严重颅内动脉粥样硬化的疗效:高分辨率MR血管壁成像研究

Efficacy of medical treatment and balloon angioplasty for severe intracranial atherosclerosis: a high-resolution MR vessel wall imaging.
PubMed 文献 · Eur Radiol · 2022-11-23

这项前瞻性研究纳入37例症状性严重颅内动脉狭窄患者,比较药物治疗与球囊血管成形术的疗效,使用HR-MRI在基线及3、6、12个月随访斑块特征。结果显示药物治疗12个月斑块缩小并趋于稳定,球囊血管成形术后6个月斑块负荷显著降低,两组缺血事件复发无差异。

要点

  • 药物治疗12个月可显著减小斑块长度、最大壁厚度和斑块强化,提示斑块趋于稳定。
  • 球囊血管成形术后6个月斑块长度、最大壁厚度和管腔狭窄均显著降低。
  • 两种治疗策略的缺血事件复发率无显著差异,治疗选择需个体化。

关键影像表现/征象

  • 药物治疗12个月时,最大斑块长度(p=0.004)、最大壁厚度(p=0.036)和斑块强化(p=0.001)较基线显著减小。
  • 球囊血管成形术后3个月,管腔狭窄较基线显著减轻(p=0.048)。
  • 球囊血管成形术后6个月,最大斑块长度(p=0.011)、最大壁厚度(p=0.003)和管腔狭窄(p=0.001)较基线显著减小。

临床应用与阅片要点

  • HR-MRI可用于随访评估颅内动脉粥样硬化斑块的形态和强化变化,辅助判断治疗反应。
  • 药物治疗后斑块强化和壁厚度下降可能提示斑块稳定,报告时可描述这些变化。
  • 球囊血管成形术后早期管腔狭窄改善,6个月时斑块负荷降低,随访影像应关注斑块长度和壁厚度。

局限性

  • 样本量较小(37例患者,68个斑块),可能影响统计效能和结果外推。
  • 单中心前瞻性研究,结果需多中心验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the efficacy of medical treatment and balloon angioplasty for intracranial atherosclerosis using high-resolution MR vessel wall imaging (HR-MRI).

METHODS: In this prospective study, patients with symptomatic severe stenosis from January 2018 to August 2021 were treated with medical treatment or balloon angioplasty. The patients underwent HR-MRI at baseline and at 3, 6, and 12 months. Plaque characteristics at follow-up were compared with those at baseline using paired sample T-test or Wilcoxon rank sum test. The difference in the recurrence of ischemic events between two groups was compared.

RESULTS: A total of 37 patients (26 males; mean age = 60.5 ± 11.6 years) were evaluated. Of 68 plaques, 42 (61.8%) were treated with medication only. At 12 months of medical treatment, maximum plaque length (p = 0.004), maximum wall thickness (p = 0.036), and plaque enhancement (p = 0.001) were significantly reduced than baseline. At 3 months after balloon angioplasty, luminal stenosis (p = 0.048) was significantly reduced compared to baseline. At 6 months after balloon angioplasty, maximum plaque length (p = 0.011), maximum wall thickness (p = 0.003), and luminal stenosis (p = 0.001) were significantly reduced than baseline. No difference was found in the recurrence of ischemic events between two groups (p = 0.458).

CONCLUSION: Intracranial atherosclerotic plaque shrank and tended to be stable at 12 months of medical treatment. Plaque burden was significantly reduced 6 months after balloon angioplasty. This may provide evidence for the application and selection of treatment strategies for intracranial atherosclerotic disease.

KEY POINTS: • Plaque burden and plaque enhancement were significantly reduced at 12 months of medical treatment compared to baseline. • Plaque burden was significantly reduced at 6 months after balloon angioplasty compared with baseline. • No significant difference in the recurrence rate of ischemic stroke between patients treated with medication and balloon angioplasty.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Huang, Jiao, Chen, et al. Efficacy of medical treatment and balloon angioplasty for severe intracranial atherosclerosis: a high-resolution MR vessel wall imaging. Eur Radiol. 2022. PMID: 36418621. doi:10.1007/s00330-022-09218-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。